- Home
- DLPN vs TLPH Comparison
DLPN vs TLPH Comparison
Compare DLPN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLPN
- TLPH
- Stock Information
- Founded
- DLPN 1996
- TLPH 2005
- Country
- DLPN United States
- TLPH United States
- Employees
- DLPN N/A
- TLPH N/A
- Industry
- DLPN Other Consumer Services
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- DLPN Consumer Discretionary
- TLPH Health Care
- Exchange
- DLPN Nasdaq
- TLPH Nasdaq
- Market Cap
- DLPN 11.9M
- TLPH 10.6M
- IPO Year
- DLPN N/A
- TLPH 2011
- Fundamental
- Price
- DLPN $1.13
- TLPH $0.44
- Analyst Decision
- DLPN Strong Buy
- TLPH Strong Buy
- Analyst Count
- DLPN 1
- TLPH 1
- Target Price
- DLPN $5.00
- TLPH $6.00
- AVG Volume (30 Days)
- DLPN 27.9K
- TLPH 43.2K
- Earning Date
- DLPN 08-13-2025
- TLPH 08-13-2025
- Dividend Yield
- DLPN N/A
- TLPH N/A
- EPS Growth
- DLPN N/A
- TLPH N/A
- EPS
- DLPN N/A
- TLPH N/A
- Revenue
- DLPN $48,618,803.00
- TLPH $27,000.00
- Revenue This Year
- DLPN $6.57
- TLPH N/A
- Revenue Next Year
- DLPN $18.10
- TLPH $14,533.26
- P/E Ratio
- DLPN N/A
- TLPH N/A
- Revenue Growth
- DLPN 0.31
- TLPH N/A
- 52 Week Low
- DLPN $0.75
- TLPH $0.43
- 52 Week High
- DLPN $2.00
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- DLPN 50.40
- TLPH 35.99
- Support Level
- DLPN $1.07
- TLPH $0.45
- Resistance Level
- DLPN $1.24
- TLPH $0.52
- Average True Range (ATR)
- DLPN 0.08
- TLPH 0.03
- MACD
- DLPN -0.01
- TLPH -0.01
- Stochastic Oscillator
- DLPN 23.81
- TLPH 11.11
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.